Literature DB >> 17141365

Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.

Loren E Clarke1, Jacqueline Junkins-Hopkins, John T Seykora, Donald J Adler, Rosalie Elenitsas.   

Abstract

A 91-year-old woman who had been taking methotrexate for approximately 5 years for rheumatoid arthritis developed papules and nodules on her face that enlarged during 6 months. A series of biopsy specimens demonstrated a lymphoplasmacytic infiltrate with increasingly atypical histopathologic features that resembled diffuse large B-cell lymphoma. Epstein-Barr virus was not identified. Withdrawal of methotrexate resulted in complete resolution of all lesions within 8 weeks. This case illustrates the rare occurrence of methotrexate-associated lymphoproliferative disorder with primary presentation in the skin and documents clinical and histopathologic progression from early changes to fully developed lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141365     DOI: 10.1016/j.jaad.2006.09.011

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Methotrexate and Pralatrexate.

Authors:  Gary S Wood; Jianqiang Wu
Journal:  Dermatol Clin       Date:  2015-08-01       Impact factor: 3.478

2.  Adverse effects of methotrexate in three psoriatic arthritis patients.

Authors:  Hideki Maejima; Akira Watarai; Toshiaki Nakano; Chieko Katayama; Hiromi Nishiyama; Kensei Katsuoka
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

Review 3.  Cutaneous manifestations associated with rheumatoid arthritis.

Authors:  T Yamamoto
Journal:  Rheumatol Int       Date:  2009-02-26       Impact factor: 2.631

Review 4.  Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?

Authors:  Helen Alexander; Thomas Patton; Zarif K Jabbar-Lopez; Andrea Manca; Carsten Flohr
Journal:  F1000Res       Date:  2019-01-31

5.  Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity.

Authors:  Jamal Z Saleh; Linda H Lee; Stefan M Schieke; Paul R Hosking; Sam T Hwang
Journal:  JAAD Case Rep       Date:  2016-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.